Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Total Non-Current Liabilities ₹199 Cr₹169 Cr₹107 Cr₹103 Cr₹78 Cr

What is the latest Total Non-Current Liabilities ratio of MANKIND PHARMA ?

The latest Total Non-Current Liabilities ratio of MANKIND PHARMA is ₹199 Cr based on Mar2023 Consolidated results.
Year Total Non-Current Liabilities
Mar2023₹199 Cr
Mar2022₹169 Cr
Mar2021₹107 Cr
Mar2020₹103 Cr
Mar2019₹78 Cr

How is Total Non-Current Liabilities of MANKIND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2023 ₹199 Cr
18.12
Mar2022 ₹169 Cr
57.15
Mar2021 ₹107 Cr
4.17
Mar2020 ₹103 Cr
32.45
Mar2019 ₹78 Cr -

Compare Total Non-Current Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹84,588.7 Cr -6.1% -11.9% 54.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,290.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹113,357.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹111,134.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹104,235.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,001.5 Cr -1% -2.4% 28.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-6.1%

-11.9%

54.1%

SENSEX

1.7%

1.5%

18.7%


You may also like the below Video Courses